Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dehydroepiandrosterone (DHEA) Treatment for Sjogren's Syndrome

NCT00001598 is registered in ClinicalTrials.gov with National Institute of Dental and Craniofacial Research (NIDCR) as lead sponsor.

NCT NCT00001598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dehydroepiandrosterone (DHEA) Treatment for Sjogren's Syndrome
Lead sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1997
Completion date
June 30, 2002
Enrollment
28
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lacrimal apparatus disease, salivary gland disease, sjogren's syndrome, xerostomia